Prevention of Postoperative Pancreatic Fistula by Somatostatin
Status:
Completed
Trial end date:
2021-02-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether somatostatin is more effective that
octreotide in the prevention of post-pancreatectomy pancreatic fistula